Publication | Open Access
Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis
89
Citations
26
References
2019
Year
InflammationLipid DisorderMedicineLiver PhysiologyPathologyHyperlipidemiaVascular BiologyPharmacotherapyHepatic SteatosisLipoprotein MetabolismFatty Liver DiseasePharmacologyAtherosclerosisDyslipidemia
| Year | Citations | |
|---|---|---|
Page 1
Page 1